digital therapeutics
Q&A: Ieso Digital Health’s SVP of AI on digital therapeutics and the new Eight Billion Minds project
A chat with Valentin Tablan, SVP of AI at British mental health startup Ieso Digital Health.
In July, MobiHealthNews will focus on how pharma companies are using digital tools for R&D, real-world evidence collection and exploring new therapeutics.
Remember that you are partners who have come together because you each have unique skills that the other cannot replicate on their own.
Longwall Venture Partners, IQ Capital and Martlet participated in the round.
Established in the US in 2013, Shanghai-headquartered QTC Care, a healthcare platform that uses AI to streamline treatment recovery and disease prevention, announced that it has raised $7M in series A funding.
Earlier this week panelists at the World Medical Innovation Forum talked validation gaps, advantages and the future of digital mental health tools.
The daily-use digital intervention yielded "clinically meaningful" improvement in blood pressure among 172 users.
Commitment to digital health varies across today’s leading pharmas, and many stakeholders are still waiting for the novel treatments to prove themselves with evidence and commercialization success.
The company has plans to work on new, streamlined design systems for the future.
At HXD 2019, a team from Kaiser Permanente described their efforts to build and populate a mental health app ecosystem for their clinicians.